Genmab — August 2012
-
fra andre selskaber
-
vil lave flere aftaler i fremtiden
-
Duobody er ranked som den bedste bispecifikke antistof platform
-
sammen med Micromet
-
Så dem der skal bygge den næste generation af antistoffer vil vælge Duobody
-
Så er der Dara !
-
snakker lovende om Dara
-
Flere aftaler kan forventes på Duobody btw
-
Partnership expected by year end
-
nemlig aka, og tror de vil blive endnu større hver gang
-
dara dræber cancerceller
-
9 bio in 2020
-
MM vokser til 9 milliarder dollar
-
MM market !!!!!!!!!!!!!!!!!!! $$$$
-
2013 Pivotal studie i Dara
-
excellent progress in partner progressions with dara
-
forventer inden udgangen af året
-
det marked som Dara sigter mod
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind